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ABSTRACT 
Acute bacterial conjunctivitis is a common, highly contagious infection in children and is usually treated empirically with 
broad spectrum topical antibiotics. In the current study we investigated bacteriology and antibiotic susceptibility 
patterns in childhood acute bacterial conjunctivitis in Western Greece. We conducted a retrospective analysis of 
presumed acute bacterial conjunctivitis cases in ''Karamandaneio'' Pediatric General Hospital of Patras, Western Greece, 
between February 1, 2013 and January 31, 2018. Specimens from the lower conjunctiva fornix were isolated from 191 
cases and outcomes were analyzed to identify the pathogenic bacteria of acute bacterial conjunctivitis and their 
corresponding antibiotic susceptibility patterns. Patients were divided into 3 groups; Group A included neonates under 
28 days of life, Group B children from 1 month to 2 years and Group C from 2 years to 14 years. Results revealed that 
Staphylococcus spp., Haemophilus spp. and Streptococcus spp. were the most prevalent pathogens. No significant 
differences in isolated pathogens were found between the age groups. Antibiotic resistance rates were higher against 
ampicillin, ceftriaxone, ceftazidime and sulfamethoxazole. Resistance rates to Ciprofloxacin were low while none of the 
evaluated isolates were resistant to vancomycin. We concluded that predominant pathogens of childhood acute 
bacterial conjunctivitis in Western Greece were Staphylococcus spp., Haemophilus spp. and Streptococcus spp. 
Continuous surveillance, focused in distinct geographic areas, is encouraged to prepare more precise protocols of 
empirical treatment. 
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INTRODUCTION
Conjunctivitis is the most frequent eye disease in 
children, accounting for an estimated of 1-4% of visits 
[1]. Acute bacterial conjunctivitis constitutes its larger 
subset, corresponding approximately to 54-73% of all 
referred cases [2]. While bacterial conjunctivitis is 
characterized as a self-limiting condition, treatment 
with topical antibiotics confers several benefits. 
Namely, the treatment can lessen the disease duration, 
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which can take up to 3 weeks untreated, palliate 
symptoms, alleviate patient discomfort, facilitate earlier 
resumption to normal activities, reduce the overall cost 
of parents’ lost productivity and children’s absence 
from school or day-care. However, bacterial 
conjunctivitis is highly contagious and rapidly 
transmitted, hence the treatment diminishes the risk of 
widespread contamination and sight-threatening 
complications [3]. The treatment is mainly empirical 
with broad-spectrum topical antibiotics [1]. Mataftsi et 
al. studied the current preferred practice among 
pediatricians, ophthalmologists and general 
practitioners in Northern Greece [4]. They reported that 
67% of pediatricians, 73% of ophthalmologists and 25% 
of general practitioners prescribe an antibiotic drop 
empirically according to clinical examination findings 
without any laboratory results.
 
 
Antibiotic resistance is the prominent factor leading to 
failure of the initial empirical treatment. Antibiotic 
resistance rates per pathogen may vary significantly in 
the course of time and in distinct geographic areas, 
mainly due to intense antibiotic use that promotes the 
resistant bacteria [5]. Carreras reported that in the 
same geographical area resistance against 
chloramphenicol and tetracyclines had diminished 
statistically significantly between 1982 and 2008, 
resistance against trimethoprim-sulfamethoxazole 
remained the same, while resistance against 
gentamicin, neomycin, erythromycin and tobramycin 
had statistically significantly increased [6]. The aim of 
the current study was to identify the pathogens 
inflicting acute bacterial conjunctivitis in children 
younger than 14 years in Western Greece and to assess 
their antibiotic susceptibility patterns.  
METHODS 
This was a single-center retrospective chart review of 
cases with presumed acute bacterial conjunctivitis 
between February 1, 2013 and January 31, 2018 in 
''Karamandaneio'' General Pediatric Hospital of Patras, 
Western Greece. The study met the ethical guidelines of 
the Declaration of Helsinki and adhered to the legal 
requirements of the ''Karamandaneio'' General 
Pediatric Hospital of Patras regarding institutional 
review board approval for in vitro investigations of 
antibiotic susceptibilities of human isolates. Also a 
written informed consent was obtained from the 
participants’ legal guardians. Inclusion criteria were 
patients younger than 14 years with a clinical diagnosis 
of acute bacterial conjunctivitis in at least one eye 
where samples for microbiological analysis were taken. 
The clinical diagnosis of acute bacterial conjunctivitis 
was based on the presence of purulent conjunctival 
discharge, crusty or sticky eyelids, bulbar conjunctival 
injection and/or ocular surface redness. Exclusion 
criteria were a history suggesting allergy, ocular trauma 
or foreign body, Kawasaki disease, Stevens-Johnson 
syndrome, administration of systemic or topical 
antibiotics during the previous week including tear 
substitutes, immunocompromisation, ocular surgery 
during the last 6 weeks, suspicion of iritis, active 
ulcerative keratitis, a history of recurrent corneal 
erosion syndrome and signs of preseptal cellulitis. Also, 
not adherence to the national vaccination program 
constituted an exclusion criterion. Patients were 
divided into 3 groups; Group A included neonates under 
28 days of life, Group B children from 1 month to 2 
years and Group C from 2 years to 14 years. Samples for 
microbiological analysis were collected in a 
standardized fashion. More precisely, the specimens 
were collected under local anesthesia with 
Proparacaine HCl 0.5% eye drops (Alcaine, Alcon 
Laboratories, Inc. Fort Worth, TX) by swabbing a cotton 
microswab (Becton Dickinson, BBL
TM
 Culture Swab 
TM
 
liquid Stuart single swab, Collection and Transport 
system) over the conjunctival lower cul-de-sac of the 
infected eye, avoiding any contact with the eyelids. All 
the microswabs were in a sealed sterile condition and 
were opened immediately before sampling. In case of 
bilateral infection, the eye with the most severe 
symptoms was selected for specimen collection. In eyes 
equally affected, the eye that was affected first was 
considered for the study. Thus, one specimen was 
collected from each patient.  
After sample collection, the microswabs were placed 
into the transport media and sent to the laboratory 
where they were streaked over chocolate, 5% sheep 
blood and MacConkey II agar plates. MacConkey agar 
plates were incubated for 48 hours at 37°C in an 
aerobic atmosphere. Chocolate and blood agar plates 
were incubated similarly supplemented with carbon 
dioxide. Anaerobic culturing was not performed. 
Cultures were assessed after two days. Bacterial 
identification was performed using standard 
biochemical laboratory procedures, according to the 
clinical and laboratory standards institute 
recommendations [7]. 
Antibiotic susceptibility testing was performed 
according to the protocols of the European Committee 
on Antimicrobial Susceptibility Testing [8] by 
microdilution on Mueller-Hinton and Haemophilus test 
medium with the Bauer-Kirby disk diffusion method 
(bioMérieux, Lyon. France). The isolated 
microorganisms were tested for susceptibility to a 
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variety of antibiotics. Based on the minimum 
inhibitory concentration breakpoints each 
microorganism was classified as susceptible (S), 
intermediate susceptible (I) and resistant (R) to the 
agent in question. Isolates exhibiting resistance to 3 or 
more drug classes were defined as multidrug-resistant 
[9]. 
Categorical variables were expressed as number and 
percentages. Distribution of continuous variables was 
assessed using a histogram. Categorical variables were 
compared using the Chi-square test. A two-tailed p<0.05 
was considered statistically significant. SPSS version 23 
statistical software (SPSS, Inc., Chicago, IL, The USA) was 
used to perform the statistical analysis. 
RESULTS 
In the current retrospective study, 191 samples from 191 
children with acute bacterial conjunctivitis (89 males, 102 
females) were analyzed. Seventy samples (36.6 %) had 
negative results for culture (Table 1). Flora was found in 8 
samples (4.2%, 3 males, 5 females) - 3 in Group A and 
Group B and 2 in Group C. These results were not 
included in the analysis. 
 
Table 1. Culture Results From Samples of Childhood Acute Bacterial 
Conjunctivitis 
Result Number of specimens Percentage 
Sterile culture 70 36.6 
Flora 8 4.2 
One organism 107 56 
Two organisms 6 3.2 
 
Microbial growth was detected in 113 bacteriological 
cultures (59.2%). More precisely, positive result for 
cultures was found in 34 neonates (Group A, 16 male and 
18 female) and included the growth of 34 isolates. To be 
noted, all newborns were delivered by vaginal delivery. 
Positive results for culture were found in 57 patients (30 
male and 27 female) of Group B with growth of 63 
microorganisms. Finally, 22 samples from Group C 
children (8 male and 14 female) had positive results for 
culture which included the growth of equal number of 
isolates. Table 2 shows the distribution of the isolated 
pathogens in each group of patients. There was no 
statistical significant difference in the incidence of 
pathogens between the 3 age groups (P = 0.084). In 
neonates, over the half of isolates were coagulase 
negative Staphylococcus spp. The second more frequent 
pathogen was S. aureus followed by S viridans. In Group 
B the most frequent pathogens were several 
Haemophilus spp. followed by Staphylococcus spp. and in 
Group C coagulase negative Staphylococcus spp. and 
several Haemophilus spp. prevailed. 
Seasonal distribution of the 3 main pathogens isolated 
was also recorded. Regarding Haemophilus spp. 43.8% of 
them were isolated during winter, while 25% in spring, 
15.6% in summer and 15.6% in autumn. Also, 42.3% of 
Staphylococcus spp. were isolated during winter, 19.2% 
in spring, 17.3% in summer and 21.2% in autumn. 
Concerning Streptococcus spp. 26.7% of samples were 
identified in winter, 26.7% in spring, 40% in summer and 
6.6% in autumn (Fig. 1).  
 
Table 2. Types and Number of Isolates Detected in Each Group with 
Childhood Acute Bacterial Conjunctivitis 
Isolated microorganism Group A Group B Group C 
Staphylococcus spp.     
Coagulase negative 19 (55.9) 10 (15.9) 7 (31.9) 
S. aureus 5 (14.7) 9 (14.3) 3 (13.6) 
Streptococcus spp.    
S. viridans 4 (11.9) 1 (1.6) 1 (4.5) 
S. pneumoniae - 9 (14.3) 3 (13.6) 
S. pyogenes - 1 (1.6) - 
Haemophilus spp.    
H. influenzae 1 (2.9) 7 (11.1) 1 (4.5) 
Other  2 (5.9) 17 (26.9) 6 (27.4) 
Corynebacterium Diphtheriae 1 (2.9) - - 
Enterobacter cloacea 1 (2.9) 1 (1.6) - 
Moraxella spp. 1 (2.9) 3 (4.7) - 
Escherichia coli - 2 (3.1) - 
Bacillus spp. - 1 (1.6) - 
Pseudomonas aeruginosa - 1 (1.6) 1 (4.5) 
Serratia marcescens - 1 (1.6) - 
Group A: included neonates under 28 days of life; Group B: children from 1 month 
to 2 years; Group C: children from 2 years to 14 years; n: number; %: percentage 
 
Figure 1. Seasonal Distribution of the 3 Main Pathogens Isolated From 
Specimens of Childhood Acute Bacterial Conjunctivitis 
 
Antibiotics sensitivity was evaluated from some of the 
isolates. Table 3 shows the sensitivity from all the 
evaluated microorganisms as well as the sensitivity from 
some isolates of S. aureus, Haemophilus spp. and 
Streptococcus spp. 
Sensitivity evaluation from all the examined 
microorganisms revealed highest resistance in ampicillin, 
ceftazidime, ceftriaxone and sulfamethoxazole. More 
precisely, of 49 evaluated microorganisms 44.9% were 
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resistant to ampicillin. Furthermore, 20.4% of the 54 
evaluated microorganisms were resistant to 
sulfamethoxazole. The resistance of all isolates to the 
most commonly empirically prescribed antibiotics in 
ophthalmology, i.e. tobramycin and ciprofloxacin were 
14.3% and 2.3% respectively. However, only a small 
number of microorganisms were tested for resistance to 
tobramycin. Staphylococcus aureus exhibited the highest 
resistance to the following antibiotics; ampicillin (84.6%) 
and ceftazidime (40%). One of 3 S. aureus isolates 
evaluated were resistant to tobramycin and 9% of the 11 
S. aureus isolates were resistant to ciprofloxacin. Highest 
resistance rates of Haemophilus spp. against antibiotics 
corresponded to ampicillin (28%) and sulfamethoxazole 
(24%). None of the isolated Haemophilus spp. exhibited 
resistance to ciprofloxacin. Streptococci spp. 
demonstrated the higher resistance against 
clarithromycin (15.4%) and sulfamethoxazole (11%). We 
did not find any vancomycin resistant isolate. Finally, we 
isolated 8 multidrug-resistant bacteria. One multidrug-
resistant microorganism was isolated in Group A, 6 in 
Group B and 1 in Group C. 
 
Table 3. Sensitivity of the Isolated Microorganisms in Childhood Acute Bacterial Conjunctivitis. The Numbers in the Parentheses Demonstrate Evaluated 
Number (n) of Isolates. (R: Resistant, S: Sensitive, I: Intermediate Resistant) 
DISCUSSION
According to our results, bacteriologic patterns of acute 
bacterial conjunctivitis in children remained similar to 
most previous studies with the Staphylococcus spp., 
Haemophilus spp. and Streptococcus spp. being the main 
isolated pathogens [2, 3, 6, 10-14]. Their frequencies, 
however, vary significantly between studies. Carreras et 
al. reported that the most frequently isolated bacteria 
were Staphylococci spp. (56.6%), Streptococci spp. 
(21.4%) and Haemophilus spp. (12.1%). While, Patel et al. 
found that H. influenzae accounted for 73%, S. 
pneumoniae 14.4% and S. aureus 2% [3, 6].
 
 The results of 
this study showed that in newborns, causative bacteria 
are inoculated from the genital tract and in older children 
vaccination against Haemophilus spp. and Streptococcus 
spp. does not affect the microbiological pattern of acute 
conjunctivitis. Haemophilus spp. were more frequently 
isolated in winter and Streptococcus spp. in summer. 
Contrary to expectations, antibiotic resistance rates in 
Western Greece were comparatively low. Our findings 
were broadly categorized in three age groups to 
investigate differences in causative pathogens between 
them. Newborns (<28 days of life) in our study, who were 
all delivered by the vaginal delivery method, were mainly 
infected by coagulase negative Staphylococcus, 
Staphylococcus aureus and Streptococcus spp. However, 
Haemophilus spp. were less frequent isolates in neonatal 
acute bacterial conjunctivitis. Our microbiologic results 
are typical for newborns, who are principally infected via 
oculogenital spread from the infected mothers, and in 
accordance with previous studies on the field, confirming 
the reported main pathogens, which are the 
predominant organisms colonizing the birth canal and 
environment [14, 15]. To examine the impact of 
vaccination on the microbiologic patterns of acute 
bacterial conjunctivitis older children were divided into 
two different groups. Regarding the most prevalent 
pathogens of acute bacterial conjunctivitis, the 
vaccination program in Greece includes vaccination with 
the Haemophilus influenzae type b (Hib) conjugate 
vaccine and 13-valent Pneumococcal conjugate vaccine 
(PCV13) until the second year of children’s life. According 
to our results, vaccination does not seem to affect the 
incidence of pathogens inflicting acute bacterial 
conjunctivitis since there were no statistically significant 
differences in the types of isolates between the age 
groups. This may be attributed to possible infection by 
 MICROORGANISM 
Antibiotics All isolated microorganisms Staphylococcus aureus Haemophilus spp. Streptococcus spp. 
 (n) R%/S%/ I% (n) R%/S%/ I% (n) R%/S%/I% (n) R%/S%/ I% 
Ampicillin   (49) 44.9%/ 55.1%/ 0% (13) 84.6%/ 15.4%/ 0% (25) 28%/ 72%/ 0% (5) 0%/ 100%/ 0% 
Cefuroxime   (60) 11.7%/ 88.3%/ 0% (15) 13.3%/ 86.7%/ 0% (31) 12.9%/ 87.1%/ 0% (8) 0%/ 100%/ 0% 
Ceftazidime   (24) 20.8%/ 70.8%/ 8.4% (10)40%/ 40%/ 20% (8) 12.5%/ 87.5%/ 0% - 
Ceftriaxone   (13) 23.1%/ 76.9%/ 0% (4) 50%/ 50%/ 0% (7) 14.3%/ 85.7%/ 0% - 
Sulfamethoxazole   (54) 20.4%/ 77.8%/ 1.8% (13) 7.7%/ 92.3%/ 0% (25) 24%/ 72%/ 4% (9) 11%/ 89%/ 0% 
Gentamicin   (14) 0%/ 100%/   0% (8) 0%/ 100%/ 0% - - 
Amikacin   (16) 0%/ 93.8%/ 6.2% (10) 0%/ 90%/ 10% - - 
Netilmicin   (5) 0%/ 100%/ 0% (5) 0%/ 100%/ 0% - - 
Tobramycin   (7) 14.3%/ 85.7%/ 0% (3) 33.3%/ 66.7%/ 0% - - 
Clarithromycin   (58) 12.1%/ 87.9%/ 0% (15) 6.7%/ 93.3%/ 0% (29) 13.8%/ 86.2%/ 0% (13) 15.4%/ 84.6%/ 0% 
Vancomycin   (14) 0%/ 100%/ 0% (6) 0%/ 100%/ 0% - (8) 0%/ 100%/ 0% 
Ciprofloxacin   (44) 2.3%/ 97.7%/ 0% (11) 9%/ 91%/ 0% (20) 0%/ 100%/ 0% (6) 0%/ 100%/ 0% 
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other serotypes or nontypeable bacteria, known as "the 
replacement phenomenon" [16, 17]. 
Antibiotic resistance patterns observed in Western 
Greece in the current study exhibited a considerable 
variation compared to previous relevant studies [2, 3, 6, 
17-19]. However, they seemed to be expectable due to 
differences in geographic areas, different periods of time 
or divergences in intensity of usage of several antibiotics 
[5, 20]. A comparative study also from Greece, and more 
precisely in the island of Crete in South Greece, found a 
decrease in resistance rates of S. aureus to several 
antibiotics from 2000 to 2009 [21]. More precisely, the 
resistance of S. aureus to tobramycin decreased from 
29.4% to 14.5%, the resistance to chloramphenicol 
decreased from 25.5% to 18.8% and the resistance to 
ciprofloxacin decreased from 3.9% to 2.9%. Another 
study from Spain reported that in 2008 the resistance 
rates of the bacteria causing conjunctivitis against several 
antibiotics like tobramycin or gentamicin, increased 
significantly compared to 1982, while the resistance rates 
to chloramphenicol diminished significantly [6]. We 
found higher resistance rates against ampicillin, 
amoxicillin/clavulanate and sulfamethoxazole. 
Interestingly, low resistance rates were found against 
tobramycin and ciprofloxacin, two antibiotics that are 
widely used topically as empiric treatment in 
ophthalmology. Nevertheless, studies of bacterial 
conjunctivitis isolates conducted from the late 1990s 
through the mid-2000s have shown increased resistance 
to tobramycin. The first annual survey of Ocular Tracking 
Resistance in the United States Today (TRUST), describing 
data collected from October 2005 to June 2006 showed 
65.3% resistance among S pneumoniae isolates to 
tobramycin and 63.6% among MRSA [22]. Furthermore, 
our results demonstrated rather low multidrug-resistant 
rates compared to other studies [2, 10, 17, 23, 24]. 
Regarding seasonal distribution, previous reports 
demonstrated that Haemophilus spp. are more 
frequently isolated in winter and Streptococcus spp. in 
summer, even corresponding percentages vary 
significantly [2, 25]. Block et al. [2] reported that 41.5% of 
total H. influenzae were isolated in winter, 33.8% of S. 
pneumoniae in summer, while Gigliotti et al. [25] 
reported that 40.5% of H. influenzae isolates were found 
in January and 52.3% from February to March. Our study 
demonstrated that most Haemophilus spp. (43.8%) and 
Staphylococcus spp. (42.3%) were isolated during winter 
while Streptococcus spp. were more prominent during 
summer (40%). 
The long duration of our study (5 years), the large 
number of antibiotics studied and its initiative nature in 
our region give strength to our study. However, we had 
some limitations. Firstly, it was a retrospective study 
conducted in a single pediatric hospital, and we are not 
sure whether our results can be generalized to larger 
population groups. Furthermore, the sample size was 
small and we did not have sensitivity results from all the 
isolated microorganisms. A small number of isolates 
were tested against Tobramycin, whereas the newer 
quinolones were not included in the sensitivity 
evaluation. Finally, cotton-tipped swabs that were used 
in the current study contain fatty acids, which may inhibit 
bacterial growth. Specimen collection under topical 
anesthetic eye drops may minimize contamination and 
result in inhibitory effects on organisms recovered. 
However, we used this sample collection method to 
minimize any possible discomfort to studied pediatrics.  
We suggest to perform more investigations regarding 
antibiotic susceptibility patterns of pathogens implicated 
in acute bacterial conjunctivitis in children in our region 
with the collaboration of more hospitals and assessing 
more antibiotics in the antibiogram, especially of newer 
quinolones, to prepare more precise local guidelines for 
empirical therapy. 
CONCLUSIONS 
The predominant pathogens of childhood acute bacterial 
conjunctivitis in Western Greece were Staphylococcus 
spp., Haemophilus spp. and Streptococcus spp. We did 
not find any statistically significantly differences in the 
isolated pathogens between the 3 age groups. Antibiotic 
resistance rates were relatively low. Low resistance rates 
against older antibiotics like tobramycin or ciprofloxacin 
highlight their significant role in the empirical treatment 
of childhood acute bacterial conjunctivitis. Continuous 
surveillance, focused in each geographic area, is 
encouraged to guide empirical treatment. 
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